Shanghai Chenguang Medical Technologies Co (BJSE:920300) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920300 Shanghai Chenguang Medical Technologies Co Ltd BJSE:920300
53 GF Score
Price ¥9.47
GF Value ¥6.57
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Shanghai Chenguang Medical Technologies Co Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Shanghai Chenguang Medical Technologies Co Valuation Rank Related Terms

BJSE:920300
53GF Score
Shanghai Chenguang Medical Technologies Co Ltd BJSE:920300
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Shanghai Chenguang Medical Technologies Co (BJSE:920300) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Chenguang Medical Technologies Co stock appears to be overvalued. The current stock price of ¥9.47 is trading 44.1% above its estimated GF Value™ of ¥6.57. GuruFocus considers Shanghai Chenguang Medical Technologies Co to be Significantly Overvalued.

Key valuation signals for BJSE:920300:

  • Valuation Rank:
  • GF Value™: ¥6.57 vs. price of ¥9.47 (44.1% above fair value)
  • GF Score™: 53/100 with 6 warning signs

No single metric tells the full story. See the BJSE:920300 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai Chenguang Medical Technologies Co Business Description

Address No. 1269, Huaqing Road, Qingpu District, Shanghai, CHN, 201707
Shanghai Chenguang Medical Technologies Co Ltd engages in research and development, production, and sales of the core hardware of medical imaging superconducting MRI equipment and special magnets in the field of scientific research. The company's product system covers hardware of superconducting MRI devices, including: RF detectors, superconducting magnets, gradient coils, RF amplifiers, gradient amplifiers.
53GF Score

Get the complete analysis for BJSE:920300

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥9.47
Price
¥6.57
GF Value